Concord Drugs Limited (BOM:538965)
India
· Delayed Price · Currency is INR 83.17
-1.32 (-1.56%)
At close: Apr 28, 2026
Concord Drugs Market Cap
Concord Drugs has a market cap or net worth of 1.12 billion as of April 29, 2026. Its market cap has increased by 251.29% in one year.
Market Cap
1.12B
Enterprise Value
1.31B
Revenue
512.41M
Ranking
n/a
PE Ratio
187.06
Stock Price
83.17
Market Cap Chart
Since February 23, 2015, Concord Drugs's market cap has increased from 144.80M to 1.12B, an increase of 673.65%. That is a compound annual growth rate of 20.07%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Denis Chem Lab | 1.07B |
| Pharmaids Pharmaceuticals | 1.07B |
| Accretion Pharmaceuticals | 1.04B |
| Bal Pharma | 1.21B |
| Mercury Laboratories | 923.94M |
| Godavari Drugs | 888.45M |
| Bilcare | 1.45B |
| Coral Laboratories | 1.47B |